Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. Eisen A, Somerfield MR, Accordino MK, Blanchette PS, et al. J Clin Oncol 2022 Jan 18:JCO2102647. doi: 10.1200/JCO.21.02647.

Read + Share

Amedeo Smart

Independent Medical Education

Eisen A, Somerfield MR, Accordino MK, Blanchette PS, et al. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. J Clin Oncol 2022 Jan 18:JCO2102647. doi: 10.1200/JCO.21.02647.
PMID: 35041467